Multi-functionality in theranostic nanoparticles: Is more always better?

Journal of Nanomedicine and Nanotechnology

Volumn 3, Issue 8, 2012, Pages 4-

  Vatansever, Fatma ^a,b   Chandran, Rakkiyappan ^a,b,c   Sadasivam, Magesh ^a,b,c   Chiang, Long Y ^d,e   Hamblin, Michael R ^a,b,f  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c AMITY UNIVERSITY   (India)

^d University of Massachusetts Lowell   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878036182     PISSN: None     EISSN: 21577439     Source Type: Journal    
DOI: 10.4172/2157-7439.1000e120     Document Type: Editorial

References (77)

1. http:/www.nano.gov/
2. Lee CW, Yang SH, Hsu CS, Meng HF (2009) Improved efficiencies in organic light emitting diodes made with CdSe/ZnS quantum dots and a semiconducting polymer. J Nanosci Nanotechnol 9: 2076-2080.
3. Alivisatos AP (1997) Scaling law for structural metastability in semiconductor nanocrystals. Berichte der Bunsengesellschaft fur physikaliche Chemie 101: 1573-1577.
4. Peng X, Schlamp MC, Kadavanich AV, Alivisatos AP (1997) Epitaxial growth of highly luminescent cdse/cds core/shell nanocrystals with photostability and electronic accessibility. J Am Chem Soc 119: 7019-7029.
5. Hines MA, Guyot-Sionnest P (1996) Synthesis and characterization of strongly luminescing ZnS-Capped CdSe nanocrystals. J Phys Chem 100: 468-471.
6. Katari JEB, Colvin VL, AP Alivisatos (1994) X-ray photoelectron spectroscopy of CdSe nanocrystals with applications to studies of the nanocrystal surface. J Phys Chem 98: 4109-4117.
7. Colvin VL, Schlamp MC, Alivisatos AP (1994) Light-emitting diodes made from cadmium selenide nanocrystals and a semiconducting polymer. Nature. 370: 354-357.
8. Weller H (1993) Colloidal semiconductor Q-particles: chemistry in the transition region between solid state and molecules. Angew Chemie Int Ed Engl 32: 41-53.
9. Murray CB, Norris DJ, Bawendi MG (1993) Synthesis and characterization of nearly monodisperse CdE (E = sulfur, selenium, tellurium) semiconductor nanocrystallites. J Am ChemSoc 115: 8706-8715.
10. Colvin VL, Goldstein AN, Alivisatos AP (1992) Semiconductor nanocrystals covalently bound to metal surfaces with self-assembled monolayers. J AmChem Soc 114: 5221-5230.
11. Wang Y (1991) Three-dimensionally confined diluted magnetic semiconductor clusters: Zn1'àíxMnxS. Solid State Commun 77: 33-38.
12. Bawendi MG, Wilson WL, Rothberg L, Carroll PJ, Jedju TM, et al. (1990) Electronic structure and photoexcited-carrier dynamics in nanometer-size CdSe clusters. Phys Rev Lett 65: 1623-1626.
13. Reed MA (1993) Quantum Dots, in Quantum Dots. Scientific American 118.
14. Bhaskar S, Tian F, Stoeger T, Kreyling W, de la Fuente JM et al. (2010) Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Part Fibre Toxicol 7: 3.
15. Kelkar SS, Reineke TM (2011) Theranostics: combining imaging and therapy. Bioconjug Chem 22: 1879-1903.
16. Mura S, Couvreur P (2012) Nanotheranostics for personalized medicine. Adv Drug Deliv Rev.
17. Xie, J, Liu G, Eden HS, Ai H, Chen X (2011) Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy. Acc Chem Res 44: 883-892.
18. Ma X, Zhao Y, Liang XJ (2011) Theranostic nanoparticles engineered for clinic and pharmaceutics. Acc Chem Res 44: 1114-1122.
19. Xie J, Lee S, Chen X (2010) Nanoparticle-based theranostic agents. Adv Drug Deliv Rev 62: 1064-1079.
20. Alexis F, Pridgen E, Molnar LK, Farokhzad OC (2008) Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 5: 505-515.
21. Niidome T, Huang L (2002) Gene therapy progress and prospects: nonviral vectors. Gene Ther 9: 1647-1652.
22. Akhtar S (2006) Non-viral cancer gene therapy: beyond delivery. Gene Ther 13: 739-740.
23. Matsumoto Y, Itaka K, Yamasoba T, Kataoka K (2009) Intranuclear fluorescence resonance energy transfer analysis of plasmid DNA decondensation from nonviral gene carriers. J Gene Med 11: 615-623.
24. Schwille P (2001) Fluorescence correlation spectroscopy and its potential for intracellular applications. Cell Biochem Biophys 34: 383-408.
25. Sahoo H, Schwille P (2011) FRET and FCS--friends or foes? Chemphyschem 12: 532-541.
26. Remaut K, Lucas B, Raemdonck K, Braeckmans K, Demeester J, et al. (2007) Can we better understand the intracellular behavior of DNA nanoparticles by fluorescence correlation spectroscopy? J Control Release 121: 49-63.
27. Ho YP, Chen HH, Leong KW, Wang TH (2006) Evaluating the intracellular stability and unpacking of DNA nanocomplexes by quantum dots-FRET. J Control Release 116: 83-89.
28. Xie R, Chen K, Chen X, Peng X (2008) InAs/InP/ZnSe Core/Shell/Shell quantum dots as near-infrared emitters: bright, narrow-band, non-cadmium containing, and biocompatible. Nano Res 1: 457-464.
29. Gao X, Cui Y, Levenson RM, Chung LW, Nie S (2004) In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 22: 969-976.
30. Bagalkot V, Zhang L, Levy-Nissenbaum E, Jon S, Kantoff PW, et al. (2007) Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett 7: 3065-3070.
31. Willard DM, Van Orden A (2003) Quantum dots: Resonant energy-transfer sensor. Nat Mater 2: 575-576.
32. Bakalova R, Ohba H, Zhelev Z, Ishikawa M, Baba Y (2004) Quantum dots as photosensitizers? Nat Biotechnol 22: 1360-1361.
33. Yaghini E, Seifalian AM, MacRobert AJ (2009) Quantum dots and their potential biomedical applications in photosensitization for photodynamic therapy. Nanomedicine (Lond) 4: 353-363.
34. Samia AC, Chen X, Burda C (2003) Semiconductor quantum dots for photodynamic therapy. J Am Chem Soc 125: 15736-15737.
35. Tsay JM, Trzoss M, Shi L, Kong X, Selke M, et al. (2007) Singlet oxygen production by Peptide-coated quantum dot-photosensitizer conjugates. J Am Chem Soc 129: 6865-6871.
36. Rakovich A, Savateeva D, Rakovich T, Donegan JF, Rakovich YP, et al. (2010) CdTe quantum dot/dye hybrid system as photosensitizer for photodynamic therapy. Nanoscale Res Lett 5: 753-760.
37. Hu M, Chen J, Li ZY, Au L, Hartland GV, et al. (2006) Gold nanostructures: engineering their plasmonic properties for biomedical applications. Chem Soc Rev 35: 1084-1094.
38. Chen J, Saeki F, Wiley BJ, Cang H, Cobb MJ, et al. (2005) Gold nanocages: bioconjugation and their potential use as optical imaging contrast agents. Nano Lett 5: 473-477.
39. Jain PK, Huang X, El-Sayed IH, El-Sayed MA (2008) Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. Acc Chem Res 41: 1578-1586.
40. Gibson JD, Khanal BP, Zubarev ER (2007) Paclitaxel-functionalized gold nanoparticles. J Am Chem Soc 129: 11653-11661.
41. Chen YH, Tsai CY, Huang PY, Chang MY, Cheng PC, et al. (2007) Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model. Mol Pharm 4: 713-722.
42. Paciotti GF, Myer L, Weinreich D, Goia D, Pavel N, et al. (2004) Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv 11: 169-183.
43. Powell AC, Paciotti GF, Libutti SK (2010) Colloidal gold: a novel nanoparticle for targeted cancer therapeutics. Methods Mol Biol 624: 375-84.
44. Cheng Y, C Samia A, Meyers JD, Panagopoulos I, Fei B, et al. (2008) Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. J Am Chem Soc 130: 10643-10647.
45. Prabaharan M, Grailer JJ, Pilla S, Steeber DA, Gong S (2009) Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery. Biomaterials 30: 6065-6075.
46. Lee S, Chen X (2009) Dual-modality probes for in vivo molecular imaging. Mol Imaging 8: 87-100.
47. Xie J, Huang J, Li X, Sun S, Chen X (2009) Iron oxide nanoparticle platform for biomedical applications. Curr Med Chem 16: 1278-1294.
48. Fabbro C, Ali-Boucetta H, Da Ros T, Kostarelos K, Bianco A, et al. (2012) Targeting carbon nanotubes against cancer. Chem Commun (Camb) 48: 3911-3926.
49. Prato M, Kostarelos K, Bianco A (2008) Functionalized carbon nanotubes in drug design and discovery. Acc Chem Res 41: 60-68.
50. Liu Z, Tabakman SM, Chen Z, Dai H (2009) Preparation of carbon nanotube bioconjugates for biomedical applications. Nat Protoc 4: 1372-1382.
51. Welsher K, Liu Z, Sherlock SP, Robinson JT, Chen Z, et al. (2009) A route to brightly fluorescent carbon nanotubes for near-infrared imaging in mice. Nat Nanotechnol 4: 773-780.
52. Wang X, Wang C, Cheng L, Lee ST, Liu Z (2012) Noble metal coated singlewalled carbon nanotubes for applications in surface enhanced Raman scattering imaging and photothermal therapy. J Am Chem Soc 134: 7414-7422.
53. Yang ST, Luo J, Zhou Q, Wang H (2012) Pharmacokinetics, metabolism and toxicity of carbon nanotubes for biomedical purposes. Theranostics 2: 271-282.
54. Chen Z, Ma L, Liu Y, Chen C (2012) Applications of functionalized fullerenes in tumor theranostics. Theranostics 2: 238-250.
55. Shen H, Zhang L, Liu M, Zhang Z (2012) Biomedical applications of graphene. Theranostics 2: 283-294.
56. Liu Z, XJ Liang (2012) Nano-carbons as theranostics. Theranostics 2: 235-237.
57. Huang P, Lin J, Wang X, Wang Z, Zhang C, et al. (2012) Light-triggered theranostics based on photosensitizer-conjugated carbon dots for simultaneous enhanced-fluorescence imaging and photodynamic therapy. Adv Mater 24: 5104-5110.
58. Sharma SK, Chiang LY, Hamblin MR (2011) Photodynamic therapy with fullerenes in vivo: reality or a dream? Nanomedicine (Lond) 6: 1813-1825.
59. Cao X, Lin W, Zheng K, He L (2012) A near-infrared fluorescent turn-on probe for fluorescence imaging of hydrogen sulfide in living cells based on thiolysis of dinitrophenyl ether. Chem Commun (Camb).
60. Wu-Zhang AX, Murphy AN, Bachman M, Newton AC (2012) Isozyme-specific interaction of protein kinase cdelta (PKCdelta) with mitochondria dissected using live cell fluorescence imaging. J Biol Chem.
61. Steunenberg P, Ruggi A, van denberg NS, Buckle T, Kuil J, et al. (2012) Phosphorescence imaging of living cells with amino acid-functionalized tris(2-phenylpyridine)iridium(III) complexes. Inorg Chem 51: 2105-2114.
62. Wanek J, Blair NP, Shahidi M (2012) Outer retinal oxygen consumption of rat by phosphorescence lifetime imaging. Curr Eye Res 37: 132-137.
63. Yallapu MM, Othman SF, Curtis ET, Gupta BK, Jaggi M, et al. (2011) Multifunctional magnetic nanoparticles for magnetic resonance imaging and cancer therapy. Biomaterials 32: 1890-1905.
64. Xie J, Jon S (2012) Magnetic nanoparticle-based theranostics. Theranostics 2: 122-124.
65. Beard P (2011) Biomedical photoacoustic imaging. Interface Focus 1: 602-631.
66. Hu S, Wang LV (2010) Photoacoustic imaging and characterization of the microvasculature. J Biomed Opt 15: 011101.
67. Weinstein DA, Krisnangkura K, Mayfield MB, Gold MH (1980) Metabolism of radiolabeled beta-guaiacyl ether-linked lignin dimeric compounds by phanerochaete chrysosporium. Appl Environ Microbiol 39: 535-540.
68. Jalilian AR, Khoshdel MR, Garousi J, Yousefnia H, Hosseini MA, et al. (2009) Development of a radiolabeled beta-human chorionic gonadotropin. Acta Pharm 59: 421-429.
69. Hobbs RF, Song H, Watchman CJ, Bolch WE, Aksnes AK, et al. (2012) A bone marrow toxicity model for (2)(2)(3)Ra alpha-emitter radiopharmaceutical therapy. Phys Med Biol 57: 3207-3222.
70. Peñuelas I, Domínguez-Prado I, García-Velloso MJ, Martí-Climent JM, Rodríguez-Fraile M, et al. (2012) PET Tracers for Clinical Imaging of Breast Cancer. J Oncol 2012: 710561.
71. Oude Munnink TH, Nagengast WB, Brouwers AH, Schröder CP, Hospers GA, et al. (2009) Molecular imaging of breast cancer. Breast 3: S66-73.
72. Chen W, Zhang J (2006) Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. J Nanosci Nanotechnol 6: 1159-1166.
73. Apostolova I, Wunder A, Dirnagl U, Michel R, Stemmer N, et al. (2012) Brain perfusion SPECT in the mouse: Normal pattern according to gender and age. Neuroimage.
74. Weber AL (1992) Magnetic resonance imaging and computed tomography of the internal auditory canal and cerebellopontine angle. Isr J Med Sci 28: 173-182.
75. Shenton ME, Hamoda HM, Schneiderman JS, Bouix S, Pasternak O, et al. (2012) A review of magnetic resonance imaging and diffusion tensor imaging findings in mild traumatic brain injury. Brain Imaging Behav 6: 137-192.
76. Garimella PD, Datta A, Romanini DW, Raymond KN, Francis MB (2011) Multivalent, high-relaxivity MRI contrast agents using rigid cysteine-reactive gadolinium complexes. J Am Chem Soc 133: 14704-14709.
77. Bouchlaka MN (2012) Mechanical disruption of tumors by iron particles and magnetic field application results in increased anti-tumor immune responses. PLoS ONE.